ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
O'Toole
Dermot
D
Department of Gastroentereology and Clinical Medicine, St. James's Hospital and Trinity College, Dublin 8, Ireland. otooled1@tcd.ie
Grossman
Ashley
A
Gross
David
D
Delle Fave
Gianfranco
G
Barkmanova
Jaroslava
J
O'Connor
Juan
J
Pape
Ulrich-Frank
UF
Plöckinger
Ursula
U
D015415:Biomarkers / Q000097:blood / Q000378:metabolism* / Q000652:urine; D053379:Chromogranin A / Q000097:blood / Q000378:metabolism; D005215:Fasting / Q000378:metabolism; D015408:Gastrinoma / Q000175:diagnosis / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism / Q000652:urine; D007003:Hypoglycemia / Q000175:diagnosis; D007340:Insulinoma / Q000175:diagnosis / Q000378:metabolism; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000378:metabolism* / Q000628:therapy; D012633:Secretin / Q000378:metabolism
D015415:Biomarkers; D053379:Chromogranin A; D012633:Secretin; D006897:Hydroxyindoleacetic Acid